2-(2-(4-chlorophenyl)ethoxy)adenosine,
MRE0094,
Sonedenoson,
2-[2-(4-Chlorophenyl)ethoxy]adenosine,
131865-88-8,
UNII-2OT4KAG5JL,
MRE0094,
2OT4KAG5JL,
CHEMBL1950553,
2-(2-(4-chlorophenyl)ethoxy)adenosine,
Sonedenoson [USAN:INN],
Sonedenoson (USAN),
SCHEMBL1094594,
CTK0G9337,
DTXSID90157239,
WUCQGGOGHZRELS-LSCFUAHRSA-N,
MRE-0094,
ZINC3966398,
BDBM50364043,
2-[2-(4chlorophenyl)ethoxy]adenosine,
AKOS027446939,
API0014023,
DB12443,
2-[2-(4-chlorophenyl)ethoxy]-adenosine,
AN-32264,
Adenosine, 2-[2-(4-chlorophenyl)ethoxy]-,
FT-0664892,
D09003,
865C888,
9-beta-D-Ribofuranosyl-2-(2-(4-chlorophenyl)ethoxy)-9H-purin-6-amine,
(2R,3R,4S,5R)-2-[6-amino-2-[2-(4-chlorophenyl)ethoxy]purin-9-yl]-5-(hydroxymethyl)tetrahydrofuran-3,4-diol,
Sonedenoson [USAN],
MRE 0094,
CID9910098,
C476036,
(2R,3R,4S,5R)-2-[6-amino-2-[2-(4-chlorophenyl)ethoxy]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol,